Calculate the 4Ts score for heparin-induced thrombocytopenia (HIT) probability. Classifies patients as low, intermediate, or high risk with actionable guidance.
The 4Ts Score Calculator estimates the pretest probability of heparin-induced thrombocytopenia (HIT), a serious immune-mediated reaction to heparin therapy. HIT occurs when antibodies form against the heparin-platelet factor 4 complex, leading to platelet activation, thrombocytopenia, and paradoxically increased risk of thrombosis.
The 4Ts scoring system evaluates four clinical criteria: the degree of Thrombocytopenia, the Timing of platelet count fall, the presence of Thrombosis or other sequelae, and whether oTher causes of thrombocytopenia can explain the clinical picture. Each component is scored 0, 1, or 2 points for a maximum total of 8.
Developed by Lo et al. and validated in multiple studies, the 4Ts score has a high negative predictive value for low-probability scores (0–3), making it particularly useful for ruling out HIT. Intermediate and high scores warrant further laboratory testing including immunoassays and the serotonin release assay (SRA), considered the gold standard for HIT confirmation. Check the example with realistic values before reporting.
HIT is a potentially life-threatening condition that requires rapid clinical decision-making. The 4Ts score provides a standardized, evidence-based framework for assessing HIT probability at the bedside, helping clinicians decide whether to discontinue heparin, initiate alternative anticoagulation, and order confirmatory testing.
Using this calculator reduces diagnostic uncertainty and helps avoid both the dangers of continued heparin exposure in true HIT and the unnecessary cost and risk of alternative anticoagulants when HIT is unlikely.
4Ts Score = Thrombocytopenia (0-2) + Timing (0-2) + Thrombosis (0-2) + oTher causes (0-2) Score Interpretation: • 0–3 = Low probability (~1-3% chance of HIT) • 4–5 = Intermediate probability (~14% chance of HIT) • 6–8 = High probability (~64-100% chance of HIT) Platelet Drop % = ((Baseline − Nadir) / Baseline) × 100
Result: 6 / 8 — High Probability
A patient with >50% platelet fall (2 pts), onset on day 7 of heparin (2 pts), no thrombosis (0 pts), and no other identifiable cause (2 pts) scores 6/8, placing them in the high probability category. Non-heparin anticoagulation should be initiated and HIT antibody testing sent.
HIT is a prothrombotic disorder caused by antibodies that recognize complexes of platelet factor 4 (PF4) and heparin. These antibodies activate platelets, leading to a paradoxical hypercoagulable state despite thrombocytopenia. HIT occurs in approximately 0.5–5% of patients exposed to unfractionated heparin and less frequently with low-molecular-weight heparin.
Untreated HIT carries a 30–75% risk of thrombosis, including deep vein thrombosis, pulmonary embolism, limb gangrene, stroke, and myocardial infarction. Mortality ranges from 10–20% without appropriate management. Early recognition using tools like the 4Ts score is critical for preventing these complications.
For low-probability scores (0–3), heparin can generally be continued with monitoring. For intermediate (4–5) and high (6–8) scores, heparin should be discontinued and replaced with a non-heparin anticoagulant. Warfarin should NOT be started until platelets recover above 150 × 10⁹/L due to risk of venous limb gangrene. Platelet transfusions are generally avoided as they may worsen thrombosis.
A score of 0–3 indicates low probability of HIT with a negative predictive value of approximately 99.8%. Most patients in this range do not have HIT and can continue heparin safely.
Calculate the 4Ts score whenever a patient on heparin develops an unexplained drop in platelet count, new thrombosis, skin necrosis at injection sites, or acute systemic reactions after heparin bolus. Use this as a practical reminder before finalizing the result.
No. The 4Ts score estimates pretest probability. Definitive diagnosis requires laboratory confirmation with an immunoassay (e.g., ELISA for PF4/heparin antibodies) and ideally a functional assay like the serotonin release assay (SRA).
HIT type I is a non-immune, benign, transient drop in platelets within the first 2 days of heparin, usually self-limiting. HIT type II is the immune-mediated form (what the 4Ts score assesses) that is clinically significant and associated with thrombosis.
Many guidelines recommend switching to a non-heparin anticoagulant (argatroban, bivalirudin, or fondaparinux) for intermediate scores while awaiting laboratory results, given the significant (~14%) probability of HIT. Keep this note short and outcome-focused for reuse.
A systematic review showed the 4Ts score has a pooled negative predictive value of 99.8% for low scores, making it excellent for ruling out HIT. However, its positive predictive value for high scores is moderate (~50-64%), so confirmatory testing is still needed.